The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.
Around 85% of strokes are due to a blocked blood vessel in the brain, known as an ischaemic stroke. This guide explains what an ischaemic stroke is, what can cause you to have one, and how it is usually diagnosed and treated.
Our policy positions set out in detail where we stand on big issues that affect stroke survivors and the wider world of stroke.
The European Stroke Organisation Conference (ESOC) 2018 took place between 16-18 May in Gothenburg, Sweden. The third day of ESOC featured new research which identified how to improve stroke care worldwide – from simple measures in low to middle-income countries, through to refinement of advanced techniques for acute and preventative stroke treatments.
The second day of ESOC highlighted the value of collaborations between professional societies and patient representatives for the advancement of stroke care. It saw the launch of the Stroke Action for Europe (2018-2030), a major collaborative initiative between the principal professional and patient organisations setting ambitious targets for stroke care over the next decade.
You might be given blood-thinning medications after you've had a stroke, to help you avoid another one. Or you might need blood-thinning medication if you have a health condition such as a heart problem or blood-clotting disorder which could lead to a stroke.
We want the research we fund to make a difference in people’s lives. That’s why we think it’s important for researchers to involve stroke survivors in their projects. Stroke survivors’ experiences can improve the quality of research, and help researchers to be more confident that their work will benefit people affected by stroke.